Scholarlink

<p>Surgical repair of rotator cuff injuries is frequently complicated by high retear rates, driven by persistent inflammation and inadequate tissue regeneration. Exosomes derived from M2 macrophages represent a promising therapeutic avenue due to their innate immunomodulatory and regenerative properties. However, their clinical application is hindered by low yields and complex purification processes. In this study, we employed an extrusion technique to isolate exosome mimetics from platelet-rich plasma (PRP) pretreated M2 macrophages. These engineered vesicles, termed PRP-M2-EM, acquired additional bioactive factors from PRP, which significantly enhanced their pro-angiogenic and immunoregulatory functions compared to standard M2-EM. This biomimetic engineering strategy successfully transposes the therapeutic benefits of PRP into a stable, nanoscale delivery system, overcoming the limitations of PRP’s short half-life and high production costs. Mechanistically, we identified the enrichment of miR-21a-5p within PRP-M2-EM as a primary driver of their superior efficacy. Further mechanistic investigation revealed that the high expression of miR-21a-5p in PRP-M2-EM targets and inhibits the tissue inhibitor of metalloproteinase 3 (TIMP3) gene, facilitating a regenerative environment. In conclusion, our study introduces engineered PRP-M2-EM as a potential therapeutic strategy. This approach promotes rotator cuff regeneration through enhanced angiogenesis and immunomodulation, with the miR-21a-5p/TIMP3 axis potentially contributing to these effects.</p> Graphical Abstract <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Platelet-rich plasma cues program M2 macrophage–derived exosome mimetics to regenerate the tendon–bone interface

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年6月2日

查看全文
  • Chihao Lin,
  • Hongyi Jiang,
  • Linjie Chen,
  • Liang Zhu,
  • Yuhan Wang,
  • Hanting Shen,
  • Zhongnan Lin,
  • Junfeng Shi,
  • Jilong Wang,
  • Junjie Deng,
  • Xiaoyun Pan

摘要

Surgical repair of rotator cuff injuries is frequently complicated by high retear rates, driven by persistent inflammation and inadequate tissue regeneration. Exosomes derived from M2 macrophages represent a promising therapeutic avenue due to their innate immunomodulatory and regenerative properties. However, their clinical application is hindered by low yields and complex purification processes. In this study, we employed an extrusion technique to isolate exosome mimetics from platelet-rich plasma (PRP) pretreated M2 macrophages. These engineered vesicles, termed PRP-M2-EM, acquired additional bioactive factors from PRP, which significantly enhanced their pro-angiogenic and immunoregulatory functions compared to standard M2-EM. This biomimetic engineering strategy successfully transposes the therapeutic benefits of PRP into a stable, nanoscale delivery system, overcoming the limitations of PRP’s short half-life and high production costs. Mechanistically, we identified the enrichment of miR-21a-5p within PRP-M2-EM as a primary driver of their superior efficacy. Further mechanistic investigation revealed that the high expression of miR-21a-5p in PRP-M2-EM targets and inhibits the tissue inhibitor of metalloproteinase 3 (TIMP3) gene, facilitating a regenerative environment. In conclusion, our study introduces engineered PRP-M2-EM as a potential therapeutic strategy. This approach promotes rotator cuff regeneration through enhanced angiogenesis and immunomodulation, with the miR-21a-5p/TIMP3 axis potentially contributing to these effects.

Graphical Abstract